Guardant Health, Inc.
GH
Price:
$33
Market Cap:
$4.04B
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay wit...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2018-10-04
Stock Exchange
NASDAQ
Ticker
GH
The ROE as of July 2024 (TTM) for Guardant Health, Inc. (GH) is -246.47%
According to Guardant Health, Inc.’s latest financial reports and current stock price. The company's current ROE is -246.47%. This represents a change of 182.62% compared to the average of -87.21% of the last 4 quarters.
Guardant Health, Inc. (GH) Historical ROE (quarterly & annually)
How has GH ROE performed in the past?
The mean historical ROE of Guardant Health, Inc. over the last ten years is -197.43%. The current -246.47% ROE has changed 24.84% with respect to the historical average. Over the past ten years (40 quarters), GH's ROE was at its highest in in the March 2023 quarter at 299.73%. The ROE was at its lowest in in the December 2022 quarter at -232.53%.
Average
-197.43%
Median
-42.43%
Minimum
-1087.72%
Maximum
-8.50%
Guardant Health, Inc. (GH) ROE by Quarter and Year
Discovering the peaks and valleys of Guardant Health, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.72%
Maximum Annual ROE = -8.50%
Minimum Annual Increase = -72.22%
Minimum Annual ROE = -1087.72%
| Year | ROE | Change |
|---|---|---|
| 2023 | -302.14% | -72.22% |
| 2022 | -1087.72% | 1.72% |
| 2021 | -59.65% | 214.52% |
| 2020 | -18.97% | 123.18% |
| 2019 | -8.50% | -51.73% |
| 2018 | -17.61% | -34.71% |
| 2017 | -26.97% | -53.42% |
Guardant Health, Inc. (GH) Average ROE
How has GH ROE performed in the past?
The current ROE of Guardant Health, Inc. (GH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-483.17%
5-year avg
-295.40%
10-year avg
-197.43%
Guardant Health, Inc. (GH) ROE vs. Peers
How is GH’s ROE compared to its peers?
Guardant Health, Inc.’s ROE is less than Invitae Corporation (472.72%), greater than Illumina, Inc. (-21.56%), greater than Twist Bioscience Corporation (-31.61%), greater than Natera, Inc. (-49.72%), greater than CareDx, Inc (-55.64%), greater than Myriad Genetics, Inc. (-30.89%), greater than Castle Biosciences, Inc. (-7.91%), greater than Personalis, Inc. (-64.15%), less than Agilent Technologies, Inc. (20.87%), less than Thermo Fisher Scientific Inc. (13.48%), less than Danaher Corporation (8.04%), less than Charles River Laboratories International, Inc. (12.72%),
| Company | ROE | Market cap |
|---|---|---|
| 472.72% | $5.44M | |
| -21.56% | $19.18B | |
| -31.61% | $3.38B | |
| -49.72% | $12.61B | |
| -55.64% | $990.11M | |
| -30.89% | $2.50B | |
| -7.91% | $581.41M | |
| -64.15% | $179.19M | |
| 20.87% | $40.06B | |
| 13.48% | $231.76B | |
| 8.04% | $197.82B | |
| 12.72% | $12.03B |
Build a custom stock screener for Guardant Health, Inc. (GH) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guardant Health, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Guardant Health, Inc. (GH) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Guardant Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Guardant Health, Inc.'s ROE?
How is the ROE calculated for Guardant Health, Inc. (GH)?
What is the highest ROE for Guardant Health, Inc. (GH)?
What is the 3-year average ROE for Guardant Health, Inc. (GH)?
What is the 5-year average ROE for Guardant Health, Inc. (GH)?
How does the current ROE for Guardant Health, Inc. (GH) compare to its historical average?